USD10
ALXO Shares
About ALX Oncology HoldingsALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

USD10
ALXO Shares
About ALX Oncology HoldingsALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Stats

TRADING WINDOW

Open

CLOSES AT

8:00 PM GMT+0

MARKET CAP

$275.17M

OPEN PRICE

$1.91

LOW (1Y)

$0.96

HIGH (1Y)

$2.66

LOW (24H)

$1.90

HIGH (24H)

$2.00

VOLUME (24H)

$1.24M

236.43%

Price history

Time
Price
Change
Today
$1.91
4.19%
1 Day
$1.93
3.11%
1 Week
$2.00
0.50%
1 Month
$2.00
0.50%
1 Year
$1.03
93.20%
Past performance is not a reliable indicator of future results.

Discover more

Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.